# Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine

> **NCT00224302** · PHASE4 · COMPLETED · sponsor: **Central Institute of Mental Health, Mannheim** · enrollment: 20 (estimated)

## Conditions studied

- Psychotic Disorders

## Interventions

- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT00224302
- **Lead sponsor:** Central Institute of Mental Health, Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224302, "Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00224302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*